| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99284 |
Emergency department visit for the evaluation and management, high severity |
11,899 |
10,135 |
$2.89M |
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
7,355 |
6,354 |
$1.44M |
| 0202U |
Oncology (prostate), multianalyte, gene expression profiling |
3,480 |
3,024 |
$1.28M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
2,830 |
2,433 |
$761K |
| 71046 |
Radiologic examination, chest; 2 views |
5,764 |
4,988 |
$519K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
4,962 |
4,282 |
$359K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
7,731 |
6,445 |
$302K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
5,332 |
4,211 |
$238K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
2,052 |
1,738 |
$157K |
| 80053 |
Comprehensive metabolic panel |
12,301 |
10,563 |
$101K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
3,794 |
3,095 |
$90K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
8,661 |
7,613 |
$52K |
| 36415 |
Collection of venous blood by venipuncture |
19,247 |
15,909 |
$46K |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
262 |
227 |
$39K |
| 87801 |
Infectious agent detection by nucleic acid; amplified probe, multiple organisms |
534 |
493 |
$39K |
| 74019 |
|
216 |
194 |
$37K |
| 71045 |
Radiologic examination, chest; single view |
565 |
477 |
$36K |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
290 |
276 |
$35K |
| 74018 |
|
342 |
301 |
$30K |
| 70450 |
Computed tomography, head or brain; without contrast material |
58 |
54 |
$23K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
690 |
643 |
$23K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
678 |
631 |
$22K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
651 |
604 |
$21K |
| 85027 |
|
2,919 |
2,459 |
$16K |
| 84443 |
Thyroid stimulating hormone (TSH) |
1,009 |
927 |
$14K |
| 80061 |
Lipid panel |
1,400 |
1,273 |
$14K |
| 81001 |
|
4,058 |
3,557 |
$11K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
248 |
222 |
$10K |
| 86769 |
|
187 |
146 |
$9K |
| 87581 |
|
286 |
257 |
$9K |
| 87486 |
|
284 |
257 |
$9K |
| 84439 |
|
1,020 |
946 |
$8K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
327 |
306 |
$8K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
105 |
92 |
$8K |
| J3490 |
Unclassified drugs |
1,761 |
1,088 |
$8K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
346 |
315 |
$7K |
| 84703 |
|
928 |
863 |
$7K |
| 84484 |
|
1,091 |
909 |
$7K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
277 |
227 |
$7K |
| 86696 |
|
331 |
305 |
$6K |
| 87634 |
|
88 |
81 |
$6K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
291 |
41 |
$6K |
| 83874 |
|
848 |
706 |
$6K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
51 |
36 |
$5K |
| 82553 |
|
746 |
615 |
$4K |
| 81003 |
|
2,103 |
1,892 |
$4K |
| 86677 |
|
302 |
283 |
$4K |
| 83880 |
|
254 |
213 |
$4K |
| 86695 |
|
330 |
304 |
$4K |
| 85007 |
|
1,220 |
967 |
$4K |
| 83735 |
|
866 |
752 |
$4K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
545 |
474 |
$3K |
| 86694 |
|
238 |
224 |
$3K |
| J8499 |
Prescription drug, oral, non chemotherapeutic, nos |
17,602 |
9,316 |
$3K |
| 82550 |
|
833 |
698 |
$3K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
77 |
69 |
$3K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
192 |
160 |
$2K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
283 |
263 |
$2K |
| 81025 |
|
311 |
273 |
$2K |
| 70220 |
|
15 |
15 |
$2K |
| 83721 |
|
906 |
761 |
$2K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
305 |
249 |
$2K |
| Q0162 |
Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen |
235 |
195 |
$2K |
| 74022 |
|
18 |
12 |
$2K |
| 86592 |
|
381 |
349 |
$1K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
197 |
167 |
$1K |
| 82607 |
|
77 |
71 |
$980.20 |
| 80305 |
|
116 |
102 |
$968.01 |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
73 |
61 |
$910.12 |
| 83605 |
|
119 |
110 |
$746.92 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
78 |
75 |
$728.00 |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
65 |
13 |
$484.00 |
| J7510 |
Prednisolone oral, per 5 mg |
82 |
56 |
$461.65 |
| 84480 |
|
56 |
53 |
$445.23 |
| 82746 |
|
34 |
31 |
$411.60 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
55 |
54 |
$411.57 |
| 82728 |
|
33 |
30 |
$368.01 |
| 85730 |
|
118 |
102 |
$330.59 |
| 87807 |
|
19 |
17 |
$305.22 |
| 83690 |
|
73 |
58 |
$289.86 |
| 87070 |
|
32 |
27 |
$287.03 |
| 85610 |
|
128 |
115 |
$251.54 |
| 87899 |
|
17 |
14 |
$244.55 |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
7,034 |
5,292 |
$242.76 |
| 83550 |
|
33 |
30 |
$235.98 |
| 83540 |
|
34 |
31 |
$181.16 |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
57 |
52 |
$128.30 |
| 85045 |
|
33 |
30 |
$107.73 |
| 82248 |
|
21 |
12 |
$85.14 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
36 |
26 |
$73.83 |
| 85379 |
|
14 |
12 |
$71.26 |
| J7050 |
Infusion, normal saline solution, 250 cc |
15 |
13 |
$58.40 |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
24 |
14 |
$46.92 |
| 90853 |
Group psychotherapy (other than of a multiple-family group) |
1,796 |
168 |
$0.00 |